21 May 2009
Primary prophylaxis of HPV infection in surgical theatre staff – is it needed?
M Woźniak, M Leśniewska, M Kotomska, A Nowak, A Ksit-Bąbel, E Nosarzewska, P FiedorAnn Transplant 2009; 14(1): 86-86 :: ID: 880516
Abstract
Chronic HPV infection is thought to be the main causative factor in the development of cervical cancer. The predominant mode of transmission is a sexual intercourse. Factors increasing the risk of HPV infection include an early sexual initiation, large number of partners, unprotected intercourse. HPV infection prevention is now considered to be a mode of primary prophylaxis of cervical cancer A significant role in prevention and eradication of HPV infection is seen in prophylactic vaccination which fully prevents HPV type 16, 18 infections considered responsible for 70% cases of cervical cancer and HPV
type 6, 11 responsible for genital warts. Vaccination and the adherence to the rules of "safe sex" may drastically reduce the incidence of cervical cancer and the spread of infection, also among the personnel of surgical theatres who are exposed to infected body parts during the course of their work. Direct contact of nursing staff with patients, especially chronically immunosuppressed transplant recipients exposes those team members to an infection risk. Preventive vaccinations currently protect medical professionals from HBV infections by stimulating the production of protective antibody levels. It is postulated that anti-HPV vaccination should be included in the protective vaccination schedule of medical professionals at a special risk of exposure.
Keywords: Primary prophylaxis
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860